For the Inventor, By the Inventor

Enter assignee name

Dresden, Germany

Asta Medica, Aktiengesellschaft

USPTO Granted Patents = 112

CIPO Patents = 5

Trademarks = 6

Forward Citations = 1,735

Loading Chart...

Loading Chart...

188 inventors (with patents filed for the assignee):

Jurgen Engel (38 out of 81 patents)

Bernhard Kutscher (29 out of 45 patents)

Helmut Hettche (11 out of 25 patents)

4. Stefan Szelenyi (10 out of 15 patents)

5. Heinz Ulrich (10 out of 13 patents)

6. Peter Emig (8 out of 29 patents)

7. Peter Hilgard (8 out of 17 patents)

8. Alfred Olbrich (8 out of 9 patents)

9. Thomas Reissmann (7 out of 16 patents)

10. Bernd Nickel (7 out of 27 patents)

11. Dieter Sauerbier (7 out of 18 patents)

12. Joachim Goede (6 out of 16 patents)

13. Klaus Wessel (6 out of 9 patents)

14. Roland Moller (6 out of 9 patents)

15. Horst Bethge (6 out of 14 patents)

Core Competencies:

Loteprednol

Indole-3-Glyoxylamides

Phospholipid Derivatives

Amino Acid Derivatives

Erectile Dysfunction Treatments

Antihistamine Combinations

Growth Hormone Releasing

Neuropathic Pain Therapy

Tumor Treatment

Inhalation Formulations

Prostate Cancer Treatments

Thioctic Acid

112 patents: Sort by Forward Citations

1. 7022687 - Combination of loteprednol and antihistamines (2006-04-04),

2. 6919344 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2005-07-19),

3. 6538151 - Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation (2003-03-25),

4. 6479472 - Methods of using therapeutic phospholipid derivatives (2002-11-12),

5. 6436924 - Antihistamine leukotriene combinations (2002-08-20),

6. 6376550 - Pharmaceutical compositions containing tramadol for migraine (2002-04-23),

7. 6348490 - Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability (2002-02-19),

8. 6344467 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2002-02-05),

9. 6322812 - Pharmaceutical forms for the oral administration of mesna (2001-11-27),

10. 6300370 - Camomile oils having a high content of natural poly-ynes and process for their preparation (2001-10-09),

11. 6300313 - Means for treating prostate hypertrophy and prostate cancer (2001-10-09),

12. 6284787 - Use of R-(+)-&agr;-lipoic acid, R-(−)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae (2001-09-04),

13. 6284287 - Particulate formulation for administration by inhalation (2001-09-04),

14. 6258815 - Specific immunophilin ligands as antiasthmatics and immunosuppressants (2001-07-10),

15. 6251935 - Treatment of migraine by administration of &agr;-lipoic acid or derivatives thereof (2001-06-26),

ASTA MEDICA, Aktiengesellschaft is a pharmaceutical company that specialized in the development, production, and distribution of innovative medicines. They have a wide range of therapeutic areas including cardiovascular diseases, respiratory diseases, oncology, and central nervous system disorders. With a strong focus on research and development, ASTA MEDICA is committed to improving patients' lives through advanced pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

112 Patents

#2 in Dresden

#560 in Germany

#6,845 in the World

Dresden, Germany

Asta Medica, Aktiengesellschaft

Forward Citations = 1,735

188 inventors:

Jurgen Engel (38 out of 81 patents)

Bernhard Kutscher (29 out of 45 patents)

Helmut Hettche (11 out of 25 patents)

4. Stefan Szelenyi (10 out of 15 patents)

5. Heinz Ulrich (10 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…